Challenges to the optimisation of cystic fibrosis exacerbation treatment outcomes

被引：0
|
作者：
Goss, Christopher H. [1 ,2 ,3 ]
Vandevanter, Donald R. [4 ]
机构：
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[3] Seattle Children s Res Inst, CF Therapeut Dev Network Coordinating Ctr, Seattle, WA 98101 USA
[4] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 63卷 / 06期
基金：
美国国家卫生研究院;
关键词：
PULMONARY EXACERBATIONS; ANTIBIOTIC-TREATMENT; TRIAL; PLACEBO;
D O I：
10.1183/13993003.00858-2024
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Evidence continues to build regarding management of pulmonary exacerbation in cystic fibrosis. This editorial comments on the work by Waters and colleagues, noting evidence continues to build regarding the lack of efficacy of steroids in exacerbation. © 2024 European Respiratory Society. All rights reserved.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pediatric hospital in the home: clinical outcomes for treatment of a cystic fibrosis respiratory exacerbation
    Hough, Judith
    Christensen, Hannah
    PHYSIOTHERAPY THEORY AND PRACTICE, 2021, 37 (12) : 1298 - 1305
  • [2] Predictors of pulmonary exacerbation treatment in cystic fibrosis
    Sanders, Don B.
    Ostrenga, Joshua S.
    Rosenfeld, Margaret
    Fink, Aliza K.
    Schechter, Michael S.
    Sawicki, Gregory S.
    Flume, Patrick A.
    Morgan, Wayne J.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 407 - 414
  • [3] Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
    de Boer, Kaissa
    Vandemheen, Katherine L.
    Tullis, Elizabeth
    Doucette, Steve
    Fergusson, Dean
    Freitag, Andreas
    Paterson, Nigel
    Jackson, Mary
    Lougheed, M. Diane
    Kumar, Vijay
    Aaron, Shawn D.
    THORAX, 2011, 66 (08) : 680 - 685
  • [4] Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis
    Waters, Valerie
    Atenafu, Eshetu G.
    Salazar, Juliana Giraldo
    Lu, Annie
    Yau, Yvonne
    Matukas, Larissa
    Tullis, Elizabeth
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (01) : 8 - 13
  • [5] Optimizing outcomes of pulmonary exacerbations in cystic fibrosis
    Szentpetery, Sylvia
    Flume, Patrick A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (06) : 606 - 611
  • [6] Treatment of pulmonary exacerbations in cystic fibrosis
    Ng, Christabella
    Nadig, Tejaswi
    Smyth, Alan R.
    Flume, Patrick
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (06) : 679 - 684
  • [7] Daily spirometry in an acute exacerbation of adult cystic fibrosis patients
    Stephen, Michael J.
    Long, Alex
    Bonsall, Chad
    Hoag, Jeffrey B.
    Shah, Smita
    Bisberg, Dorothy
    Holsclaw, Douglas
    Varlotta, Laurie
    Fiel, Stan
    Du, Doantrang
    Zanni, Robert
    Hadjiliadis, Denis
    CHRONIC RESPIRATORY DISEASE, 2018, 15 (03) : 258 - 264
  • [8] A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment
    Goss, Christopher H.
    Heltshe, Sonya L.
    West, Natalie E.
    Skalland, Michelle
    Sanders, Don B.
    Jain, Raksha
    Barto, Tara L.
    Fogarty, Barbra
    Marshall, Bruce C.
    VanDevanter, Donald R.
    Flume, Patrick A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (11) : 1295 - 1305
  • [9] Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis
    VanDevanter, D. R.
    Heltshe, S. L.
    Spahr, J.
    Beckett, V. V.
    Daines, C. L.
    Dasenbrook, E. C.
    Gibson, R. L.
    Jain, R.
    Sanders, D. B.
    Goss, C. H.
    Flume, P. A.
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (05) : 607 - 615
  • [10] Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment
    Cogen, Jonathan D.
    Faino, Anna, V
    Onchiri, Frankline
    Gibson, Ronald L.
    Hoffman, Lucas R.
    Kronman, Matthew P.
    Rosenfeld, Margaret
    Nichols, David P.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (02) : 266 - 272
12345